Progressive Supranuclear Palsy AtypicalSymptoms, Doctors, Treatments, Advances & More
Learn About Progressive Supranuclear Palsy Atypical
- Progressive supranuclear palsy atypical
- Atypical PSP
Memory And Aging Center
Adam Boxer is a Neurologist practicing medicine in San Francisco, California. Dr. Boxer is rated as an Elite provider by MediFind in the treatment of Progressive Supranuclear Palsy Atypical. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Corticobasal Degeneration. Dr. Boxer is board certified in American Board Of Psychiatry/Neurology-Psychiatry, Neurology. Dr. Boxer is currently accepting new patients.
Matthias Brendel practices practicing medicine in Munich, Germany. Mr. Brendel is rated as an Elite expert by MediFind in the treatment of Progressive Supranuclear Palsy Atypical. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Dementia.
UChicago Medicine Duchossois Center For Advanced Medicine - Hyde Park
Tao Xie is a Neurologist practicing medicine in Chicago, Illinois. Dr. Xie is rated as an Elite provider by MediFind in the treatment of Progressive Supranuclear Palsy Atypical. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Progressive Supranuclear Palsy Atypical, Progressive Supranuclear Palsy, Supranuclear Ophthalmoplegia, Deep Brain Stimulation, and Gastrostomy. Dr. Xie is board certified in Neurology and Practicing Since2010. Dr. Xie is currently accepting new patients.
Summary: This goal of this observational study is to clarify the variations in the natural course of atypical parkinsonian syndromes (APS, including MSA, DLB, PSP, and CBD), such as the progression rate of motor and non-motor symptoms and characteristic imaging evolution patterns. Establish a comprehensive assessment framework for APS, and develop clinical and biological databases to identify biomarkers wi...
Summary: MARKERS-NDD is a prospective, observational, longitudinal study, which aims to collect data from patients affected by neurodegenerative diseases (NDD) followed longitudinally for routine examinations performed as part of normal clinical practice. Data collected from clinical evaluations, movement analysis, brain imaging, neuropsychological and electroencephalographic assessments, blood chemistry t...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center